ARTICLE
19 March 2024

Enhancing Integration Of Intellectual Property Rights And Broadening Pharmaceutical Research

AA
Adams & Adams

Contributor

Adams & Adams is an internationally recognised and leading African law firm that specialises in providing intellectual property and commercial services.
On Friday, February 2, 2024, Mr. Denis BOHOUSSOU, Director General of OAPI, welcomed a delegation from the Heads of the "Health and Globalization, Standards, Policies, Market"...
South Africa Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

On Friday, February 2, 2024, Mr. Denis BOHOUSSOU, Director General of OAPI, welcomed a delegation from the Heads of the "Health and Globalization, Standards, Policies, Market" Chair at the University of Yaoundé II.

As part of OAPI's initiatives to foster an IP-driven economy and focus on research, innovation, and development, collaboration between relevant institutions is essential to leverage patents for the commercialization of high-quality medicines. The meeting also addressed the vital role universities play in shaping public health policies in Africa. This is achieved through effective utilization of intellectual property (particularly the patent system) to encourage innovation and research in the pharmaceutical sector.

The delegation comprised Professor Germain NTONO TSIMI, Director of Academic Affairs and Cooperation at the University of Yaoundé II, Professor John TAMBUTOH DASHAKO, and Mr. Guilherme CINTRA from the IFPMA (International Federation of Pharmaceutical Manufacturers & Associations), a partner of the University of Yaoundé II within this framework.

Since 2020, OAPI and IFPMA have established a partnership enabling IFPMA's participation in the 8th and 9th editions of the African Exhibition of Invention and Innovative Enterprise (SAIIT). OAPI was also represented among the members of the Jury of the "Africa Young Innovators for Health Award" organized by IFPMA in 2021, further underscoring the collaboration between the two entities.

Source: Increasing the integration of intellectual property rights and expanding pharmaceutical research (oapi.int)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
19 March 2024

Enhancing Integration Of Intellectual Property Rights And Broadening Pharmaceutical Research

South Africa Food, Drugs, Healthcare, Life Sciences

Contributor

Adams & Adams is an internationally recognised and leading African law firm that specialises in providing intellectual property and commercial services.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More